| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |